Lockheed Martin bags $3.2 billion US Air Force contract for JASSM and LRASM
A B-1B Lancer carrying an AGM-158 Joint Air-to-Surface Standoff Missile. (Photo: US Air Force / Wikimedia Commons)
The US Air Force had awarded Lockheed Martin with a US$3.2 billion sole-source contract to produce joint air-to-surface standoff missiles (JASSM) and long-range anti-ship missiles (LRASM).
The contract focused on Lot 22 JASSM and LRASM and Foreign Military Sales (FMS) missiles for Japan, the Netherlands, Finland and Poland. As reported by Reuters, in May 2024, Poland signed a reported $735 million contact with the US for the supply of JASSM-ER (extended-range) missiles.
JASSMs – one of Lockheed’s first cruise missiles – are conventional, air-launched missiles, designed for the US Air Force and international allies, while LRASMs are precision-guided, long-range anti-ship missiles, designed to meet the demands of the US Air Force and Navy.
On 16 September 2024, Lockheed Martin unveiled its AGM-158 XR cruise missile concept, which it claimed would offer increased standoff attack range. The XR missile would also be compatible with the same platforms that deploy the JASSM and LRASM, including the F-35 Lightning II combat aircraft.
Related Equipment in Defence Insight
More from Air Warfare
-
Project Kuiper’s LEO network pioneers Space-as-a-Service
The Kuiper Network enables organizations to buy, rather than build, applications that serve mission needs at mission speed.
-
DSEI 2025: Helsing and Systematic join forces to revolutionise drone recce-strike missions
The partnership will integrate Helsing’s AI-powered systems with the Systematic SitaWare suite of C4ISR currently used by more than 50 nations, enabling faster data exchange between ISR UAVs and Helsing’s HX-2 loitering munitions.
-
Finland secures possible $1.07 billion AMRAAM deal with US State Department
The Nordic country is set to bolster its defence capabilities after its foreign military sales request for AIM-120D-3 advanced medium-range air-to-air missiles (AMRAAMs) was approved.